Drugs Approved for Pancreatic Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for pancreatic cancer. The list includes generic names and brand names.This page also lists common drug combinations used in pancreatic cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in pancreatic cancer that are not listed here.
Drugs Approved for Pancreatic Cancer
- Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
- Afinitor (Everolimus)
- Capecitabine
- Erlotinib Hydrochloride
- Everolimus
- 5-FU (Fluorouracil Injection)
- Fluorouracil Injection
- Gemcitabine Hydrochloride
- Gemzar (Gemcitabine Hydrochloride)
- Infugem (Gemcitabine Hydrochloride)
- Irinotecan Hydrochloride Liposome
- Lynparza (Olaparib)
- Mitomycin
- Olaparib
- Onivyde (Irinotecan Hydrochloride Liposome)
- Paclitaxel Albumin-stabilized Nanoparticle Formulation
- Sunitinib Malate
- Sutent (Sunitinib Malate)
- Tarceva (Erlotinib Hydrochloride)
- Xeloda (Capecitabine)
Drug Combinations Used in Pancreatic Cancer
Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors
- Afinitor Disperz (Everolimus)
Lanreotide Acetate - Lutathera (Lutetium Lu 177-Dotatate)
- Lutetium Lu 177-Dotatate
- Somatuline Depot (Lanreotide Acetate)